Kerlone (Betaxolol Hydrochloride) - Summary

KERLONE SUMMARY

Kerlone^®
betaxolol hydrochloride
tablets

Kerlone (betaxolol hydrochloride) is a β₁-selective (cardioselective) adrenergic receptor blocking agent available as 10-mg and 20-mg tablets for oral administration.

Kerlone is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics.

KERLONE NEWS HIGHLIGHTS

Published Studies Related to Kerlone (Betaxolol)

Penetration of betaxolol HCL ionic suspension 0.25% and betaxolol HCL solution 0.50% into the aqueous humor. [2007.05]

Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial. [2007]

Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial). [2006.11.10]

Effects of latanoprost and betaxolol on cardiovascular and respiratory status of newly diagnosed glaucoma patients. [2006]

Effect of betaxolol hydrochloride on heart rate variability indices during exercise stress testing in patients with hypertension. [2005.10]

more>>

Clinical Trials Related to Kerlone (Betaxolol)

Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension. [Completed]

Early Manifest Glaucoma Trial (EMGT) [Active, not recruiting]

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]

more>>